(Q37950070)

25 August 2017

title

The Singapore flagship programme in translational and clinical research in psychosis (English)

1 reference

25 August 2017

0 references

1 reference

8

1 reference

25 August 2017

Mythily Subramaniam

7

0 references

Michael Wl Chee

object named as

Michael Chee

3

0 references

Jianjun Liu

4

object named as

Jianjun Liu

1 reference

25 August 2017

6

Patrick McGorry

1 reference

25 August 2017

Siow-Ann Chong

1

1 reference

25 August 2017

Alastair Campbell

2

1 reference

25 August 2017

Christine Marx

5

1 reference

25 August 2017

Richard S E Keefe

9

1 reference

25 August 2017

publication date

1 November 2011

1 reference

Early Intervention in Psychiatry: the development, onset and treatment of emerging mental disorders

25 August 2017

published in

1 reference

25 August 2017

volume

5

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

290-300

1 reference

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Genomics and behavior. Toward behavioral genomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Copy-number polymorphisms: mining the tip of an iceberg

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Major changes in our DNA lead to major changes in our thinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Structural variation in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

The prodromal phase of first-episode psychosis: past and current conceptualizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Monitoring and care of young people at incipient risk of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Symptom assessment in schizophrenic prodromal states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Association between psychotic experiences and depression in a clinical sample over 6 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Treatment of the schizophrenia prodrome: is it presently ethical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Schizophrenia: a common disease caused by multiple rare alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Psychosis treatment prior to psychosis onset: ethical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Ethics and early intervention in psychosis: keeping up the pace and staying in step

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Research in people with psychosis risk syndrome: a review of the current evidence and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Perceptions as hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Perceptual Illusions and Brain Models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Perceptions of knowledge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Memory-prediction errors and their consequences in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Implicit learning of non-spatial sequences in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Proverb comprehension reconsidered--'theory of mind' and the pragmatic use of language in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

When doors of perception close: bottom-up models of disrupted cognition in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

A longitudinal study of neurocognitive function in individuals at-risk for psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Six-year outcomes in first admission adolescent inpatients: clinical and cognitive characteristics at admission as predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Meta-analysis of regional brain volumes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Application of automated MRI volumetric measurement techniques to the ventricular system in schizophrenics and normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Regional brain morphology and duration of illness in never-medicated first-episode patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Temporal lobe abnormalities in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Regional specificity of hippocampal volume reductions in first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Combining anatomical manifold information via diffeomorphic metric mappings for studying cortical thinning of the cingulate gyrus in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Regional gray matter volume abnormalities in the at risk mental state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Longitudinal mapping of cortical thickness and brain growth in normal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Cognitive and emotional influences in anterior cingulate cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

The role of the medial frontal cortex in cognitive control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Frontal cortex contributes to human memory formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

fMRI study of maintenance and manipulation processes within working memory in first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Changes in distributed neural circuitry function in patients with first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Anterior cingulate cortex and response conflict: effects of response modality and processing domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Altered brain activation in dorsolateral prefrontal cortex in adolescents and young adults at genetic risk for schizophrenia: an fMRI study of working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Neuroactive steroids: new biomarkers of cognitive aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Allopregnanolone attenuates N-methyl-D-aspartate-induced excitotoxicity and apoptosis in the human NT2 cell line in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Glutamate as a therapeutic target in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Pregnenolone sulfate enhances long-term potentiation in CA1 in rat hippocampus slices through the modulation of N-methyl-D-aspartate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

The neurosteroid pregnenolone sulfate blocks deficits induced by a competitive NMDA antagonist in active avoidance and lever-press learning tasks in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

The neurosteroid pregnenolone sulfate infused into the medial septum nucleus increases hippocampal acetylcholine and spatial memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

The NIMH-MATRICS consensus statement on negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Negative symptoms and specific cognitive impairments as combined targets for improved functional outcome within cognitive remediation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

Pregneolone--from Selye to Alzheimer and a model of the pregnenolone sulfate binding site on the GABAA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7893.2011.00304.X

10.1111/J.1751-7893.2011.00304.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference